BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

229 related articles for article (PubMed ID: 8714755)

  • 1. 5-Hydroxytryptamine in the central nervous system.
    Chojnacka-Wójcik E
    Pol J Pharmacol; 1995; 47(3):219-35. PubMed ID: 8714755
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cognitive dysfunction in neuropsychiatric disorders: selected serotonin receptor subtypes as therapeutic targets.
    Terry AV; Buccafusco JJ; Wilson C
    Behav Brain Res; 2008 Dec; 195(1):30-8. PubMed ID: 18241938
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Review article: serotonin receptors and transporters -- roles in normal and abnormal gastrointestinal motility.
    Gershon MD
    Aliment Pharmacol Ther; 2004 Nov; 20 Suppl 7():3-14. PubMed ID: 15521849
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Is there a relationship between serotonin receptor subtypes and selectivity of response in specific psychiatric illnesses?
    Montgomery SA; Fineberg N
    Br J Psychiatry Suppl; 1989 Dec; (8):63-9. PubMed ID: 2692641
    [TBL] [Abstract][Full Text] [Related]  

  • 5. 5-HT receptor regulation of neurotransmitter release.
    Fink KB; Göthert M
    Pharmacol Rev; 2007 Dec; 59(4):360-417. PubMed ID: 18160701
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Serotonin control of central dopaminergic function: focus on in vivo microdialysis studies.
    Di Matteo V; Di Giovanni G; Pierucci M; Esposito E
    Prog Brain Res; 2008; 172():7-44. PubMed ID: 18772026
    [TBL] [Abstract][Full Text] [Related]  

  • 7. 5-hydroxytryptamine-moduline, a new endogenous cerebral peptide, controls the serotonergic activity via its specific interaction with 5-hydroxytryptamine1B/1D receptors.
    Massot O; Rousselle JC; Fillion MP; Grimaldi B; Cloëz-Tayarani I; Fugelli A; Prudhomme N; Seguin L; Rousseau B; Plantefol M; Hen R; Fillion G
    Mol Pharmacol; 1996 Oct; 50(4):752-62. PubMed ID: 8863819
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Recent advances in neuropsychopharmacology of the central serotonin receptor].
    Yamawaki S; Hayakawa H
    Yakubutsu Seishin Kodo; 1992 Apr; 12(2):43-54. PubMed ID: 1441762
    [TBL] [Abstract][Full Text] [Related]  

  • 9. 5-hydroxytryptamine: considerations about discovery, receptor classification and relevance to medical research.
    Villalón CM; Terrón JA; Ramírez-San Juan E; Saxena PR
    Arch Med Res; 1995; 26(4):331-44. PubMed ID: 8555727
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Contributions of 5-HT(2C) receptors to multiple actions of central serotonin systems.
    Giorgetti M; Tecott LH
    Eur J Pharmacol; 2004 Mar; 488(1-3):1-9. PubMed ID: 15044029
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Serotonin receptor subtypes and affective disorders.
    Robinson DS
    Clin Neuropharmacol; 1993; 16 Suppl 3():S1-5. PubMed ID: 8131151
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Serotonin now: Part 1. Neurobiology and developmental genetics].
    Kriegebaum C; Gutknecht L; Schmitt A; Lesch KP; Reif A
    Fortschr Neurol Psychiatr; 2010 Jun; 78(6):319-31. PubMed ID: 20340067
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Serotonin and its role in colonic function and in gastrointestinal disorders.
    Costedio MM; Hyman N; Mawe GM
    Dis Colon Rectum; 2007 Mar; 50(3):376-88. PubMed ID: 17195902
    [TBL] [Abstract][Full Text] [Related]  

  • 14. 5-HT in nervous system disease and migraine.
    Fozard JR; Kalkman HO
    Curr Opin Neurol Neurosurg; 1992 Aug; 5(4):496-502. PubMed ID: 1515690
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Serotonin 5-HT(3) receptors in the central nervous system.
    Chameau P; van Hooft JA
    Cell Tissue Res; 2006 Nov; 326(2):573-81. PubMed ID: 16826372
    [TBL] [Abstract][Full Text] [Related]  

  • 16. 5-Hydroxytryptamine(1A) receptor activation enhances norepinephrine release from nerves in the rabbit saphenous vein.
    Cohen ML; Schenck KW; Hemrick-Luecke SH
    J Pharmacol Exp Ther; 1999 Sep; 290(3):1195-201. PubMed ID: 10454495
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Determining the region-specific contributions of 5-HT receptors to the psychostimulant effects of cocaine.
    Müller CP; Huston JP
    Trends Pharmacol Sci; 2006 Feb; 27(2):105-12. PubMed ID: 16406129
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Studies on the neuroendocrine role of serotonin.
    Jørgensen HS
    Dan Med Bull; 2007 Nov; 54(4):266-88. PubMed ID: 18208678
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Roles of 5-hydroxytryptamine (5-HT) receptor subtypes in the inhibitory effects of 5-HT on C-fiber responses of spinal wide dynamic range neurons in rats.
    Liu FY; Xing GG; Qu XX; Xu IS; Han JS; Wan Y
    J Pharmacol Exp Ther; 2007 Jun; 321(3):1046-53. PubMed ID: 17329553
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Physiology and pathophysiology of the serotonergic system and its implications on mental and physical performance. Part II.
    Strüder HK; Weicker H
    Int J Sports Med; 2001 Oct; 22(7):482-97. PubMed ID: 11590475
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.